CN Stock MarketDetailed Quotes

301617 Shandong Boyuan Pharmaceutical &Chemical

Watchlist

0.00
0.000.00%

Trading Dec 2 09:30 CST

0Market Cap0.00P/E (TTM)

Shandong Boyuan Pharmaceutical &Chemical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Assets

Current assets

Money funds

--310.32M

120.09%315.41M

185.66%228.52M

198.78%143.31M

72.02%80M

----

--47.96M

134.20%46.5M

-36.73%19.86M

--31.38M

Transactional financial assets

----

851.61%59M

194.01%69.15M

----

--6.2M

370.40%23.52M

-40.48%5M

--8.4M

Notes receivable and accounts receivable

--162.41M

-10.92%155.66M

76.75%155.3M

22.03%174.73M

-2.72%87.87M

----

--143.19M

4.68%90.32M

12.08%86.28M

--76.98M

-Notes receivable

--29.18M

-31.48%33.93M

76.56%63.96M

-9.55%49.52M

-29.43%36.22M

----

--54.74M

16.23%51.33M

4.57%44.16M

--42.23M

-Accounts receivable

--133.23M

-2.78%121.73M

76.89%91.35M

41.58%125.22M

32.44%51.64M

----

--88.44M

-7.42%38.99M

21.20%42.12M

--34.75M

Other receivables (including interest and dividends)

--1.72M

73.18%1.71M

533.57%4.7M

65.75%987.49K

-69.44%741.48K

----

--595.78K

-72.20%2.43M

167.76%8.73M

--3.26M

-Other receivable

----

73.18%1.71M

533.57%4.7M

65.75%987.49K

-69.44%741.48K

----

--595.78K

-72.20%2.43M

167.76%8.73M

--3.26M

Advance payment

--14.96M

1.88%12.64M

60.01%18.75M

-80.94%12.41M

-58.40%11.72M

----

--65.09M

385.92%28.17M

-50.67%5.8M

--11.75M

Inventories

--185.76M

-0.10%143.25M

24.99%171.37M

6.04%143.4M

31.79%137.1M

----

--135.22M

35.93%104.03M

-5.34%76.53M

--80.85M

Receivable financing

--1.24M

6.95%11.28M

-58.17%13.96M

-81.95%10.55M

123.68%33.39M

----

--58.43M

-40.35%14.93M

19.21%25.02M

--20.99M

Other current assets

--6.03M

361.78%4.16M

387.46%2.27M

-72.62%900K

--466.03K

----

--3.29M

----

-16.49%4.92M

--5.89M

Total current assets

--682.44M

18.12%644.1M

41.49%594.88M

18.54%545.28M

35.67%420.43M

----

--459.98M

33.50%309.89M

-3.08%232.14M

--239.51M

Non Current assets

Fixed assets

----

48.40%215.76M

53.19%218.31M

-1.33%145.39M

-5.16%142.51M

----

--147.35M

20.77%150.26M

14.22%124.42M

--108.93M

Constru in process

----

-6.65%184.63M

-20.71%144.6M

151.33%197.78M

445.89%182.36M

----

--78.69M

0.78%33.41M

-22.91%33.15M

--43M

Construction materials

----

7.29%6.25M

2.99%5.21M

-49.75%5.82M

203.63%5.06M

----

--11.59M

1.88%1.67M

87.62%1.64M

--871.55K

Intangible assets

--55.64M

-3.48%55.53M

-3.06%56.54M

0.27%57.53M

0.54%58.32M

----

--57.38M

184.20%58.01M

-19.47%20.41M

--25.34M

Deferred tax assets

--723.68K

-31.25%713.35K

85.87%669.31K

-11.89%1.04M

-49.74%360.1K

----

--1.18M

4.73%716.55K

75.86%684.18K

--389.05K

Usufruct assets

--883.86K

7.21%950.33K

-28.21%1.08M

-56.59%886.4K

-39.38%1.51M

----

--2.04M

93.94%2.49M

--1.28M

----

Other non current assets

--1.68M

-41.66%1.03M

56.23%1.72M

-94.57%1.77M

-57.34%1.1M

----

--32.66M

-59.59%2.58M

405.56%6.39M

--1.26M

Total non current assets

--470.27M

13.32%464.86M

9.43%428.13M

23.97%410.22M

57.04%391.22M

----

--330.89M

32.53%249.12M

4.55%187.97M

--179.79M

Total assets

--1.15B

16.06%1.11B

26.04%1.02B

20.82%955.49M

45.19%811.65M

--852.81M

--790.87M

33.07%559.02M

0.19%420.11M

--419.31M

Liabilities

Current liabilities

Short term loan

----

163.16%1M

----

--13.94M

-98.67%380K

-12.54%28.47M

--32.55M

Notes payable and accounts payable

--127.31M

-19.73%121.44M

6.26%144.5M

-2.54%151.29M

149.73%135.98M

----

--155.24M

-9.97%54.45M

3.10%60.49M

--58.66M

-Notes payable

--83.08M

-36.24%65.85M

9.67%97.73M

-9.60%103.27M

266.10%89.12M

----

--114.24M

-8.20%24.34M

-24.52%26.52M

--35.13M

-Accounts payable

--44.23M

15.77%55.6M

-0.22%46.77M

17.13%48.02M

55.65%46.87M

----

--41M

-11.36%30.11M

44.32%33.97M

--23.54M

Contract liabilities

--4.26M

-92.27%560.12K

53.37%4.39M

77.03%7.24M

-35.02%2.86M

----

--4.09M

87.12%4.4M

--2.35M

----

Advance receipts

----

--5.02M

Salaries payable

--11.15M

12.78%9.42M

-2.79%11.73M

1.39%8.35M

32.56%12.06M

----

--8.24M

53.50%9.1M

2.10%5.93M

--5.81M

Taxs payable

--6.74M

13.93%15.91M

53.30%6.54M

30.67%13.97M

-29.45%4.27M

----

--10.69M

616.67%6.05M

-29.42%843.95K

--1.2M

Other payable (including interest and dividends)

--351.19K

277.16%928.19K

-40.01%249.02K

-86.91%246.1K

-6.24%415.09K

----

--1.88M

30.75%442.7K

-99.33%338.59K

--50.81M

-Other payable

----

277.16%928.19K

-40.01%249.02K

-86.91%246.1K

-6.24%415.09K

----

--1.88M

30.75%442.7K

-99.33%338.59K

--50.81M

Non current liabilities due within one year

--266.23K

-49.99%263.15K

-73.64%256.98K

-51.48%526.23K

-11.06%974.98K

----

--1.08M

310.91%1.1M

--266.78K

----

Other current liabilities

--22.58M

-22.41%29.68M

78.85%46.49M

7.30%38.26M

-17.24%26M

----

--35.65M

33.70%31.41M

-18.30%23.49M

--28.76M

Total current liabilities

--172.65M

-18.95%178.21M

16.67%214.16M

-4.73%219.88M

71.02%183.56M

----

--230.81M

-12.15%107.33M

-33.17%122.18M

--182.81M

Current liabilities

Long term deferred income

----

--2.93M

Lease liabilities

--68.99K

-66.37%136.32K

-54.91%270.98K

-59.38%405.35K

-57.92%601.02K

----

--997.99K

42.04%1.43M

--1.01M

----

Total non current liabilities

--68.99K

-66.37%136.32K

-54.91%270.98K

-59.38%405.35K

-57.92%601.02K

----

--997.99K

42.04%1.43M

-65.73%1.01M

--2.93M

Total liabilities

--172.72M

-19.04%178.35M

16.44%214.43M

-4.97%220.29M

69.32%184.16M

--247.62M

--231.81M

-11.71%108.76M

-33.68%123.18M

--185.74M

Shareholders equity

Paid-in capital

--77.1M

0.00%77.1M

----

--77.1M

5.04%77.1M

0.04%73.4M

--73.37M

Capital reserve funds

--239.82M

0.12%239.58M

0.21%239.32M

0.33%239.3M

0.24%238.83M

----

--238.52M

24.58%238.25M

117.01%191.24M

--88.12M

Surplus reserve funds

--49.1M

58.95%49.1M

133.00%30.89M

----

--13.26M

352.78%13.26M

-62.69%2.93M

--7.85M

Retained profit

--613.01M

46.88%564.43M

58.93%442.03M

68.52%384.29M

132.86%278.13M

----

--228.04M

351.08%119.44M

-56.02%26.48M

--60.2M

Specific reserves

--961.46K

-88.88%403.13K

-59.22%1.03M

68.65%3.62M

14.97%2.54M

----

--2.15M

-23.34%2.21M

-28.37%2.88M

--4.02M

Shareholders equity without minority interests

--979.99M

26.58%930.61M

28.86%808.58M

31.51%735.21M

39.36%627.49M

----

--559.07M

51.64%450.26M

27.13%296.92M

--233.56M

Total shareholder equity

--979.99M

26.58%930.61M

28.86%808.58M

31.51%735.21M

39.36%627.49M

--605.19M

--559.07M

51.64%450.26M

27.13%296.92M

--233.56M

Total liabilityies and equity

--1.15B

16.06%1.11B

26.04%1.02B

20.82%955.49M

45.19%811.65M

--852.81M

--790.87M

33.07%559.02M

0.19%420.11M

--419.31M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Assets
Current assets
Money funds	--310.32M	120.09%315.41M	185.66%228.52M	198.78%143.31M	72.02%80M	----	--47.96M	134.20%46.5M	-36.73%19.86M	--31.38M
Transactional financial assets	----	----	----	851.61%59M	194.01%69.15M	----	--6.2M	370.40%23.52M	-40.48%5M	--8.4M
Notes receivable and accounts receivable	--162.41M	-10.92%155.66M	76.75%155.3M	22.03%174.73M	-2.72%87.87M	----	--143.19M	4.68%90.32M	12.08%86.28M	--76.98M
-Notes receivable	--29.18M	-31.48%33.93M	76.56%63.96M	-9.55%49.52M	-29.43%36.22M	----	--54.74M	16.23%51.33M	4.57%44.16M	--42.23M
-Accounts receivable	--133.23M	-2.78%121.73M	76.89%91.35M	41.58%125.22M	32.44%51.64M	----	--88.44M	-7.42%38.99M	21.20%42.12M	--34.75M
Other receivables (including interest and dividends)	--1.72M	73.18%1.71M	533.57%4.7M	65.75%987.49K	-69.44%741.48K	----	--595.78K	-72.20%2.43M	167.76%8.73M	--3.26M
-Other receivable	----	73.18%1.71M	533.57%4.7M	65.75%987.49K	-69.44%741.48K	----	--595.78K	-72.20%2.43M	167.76%8.73M	--3.26M
Advance payment	--14.96M	1.88%12.64M	60.01%18.75M	-80.94%12.41M	-58.40%11.72M	----	--65.09M	385.92%28.17M	-50.67%5.8M	--11.75M
Inventories	--185.76M	-0.10%143.25M	24.99%171.37M	6.04%143.4M	31.79%137.1M	----	--135.22M	35.93%104.03M	-5.34%76.53M	--80.85M
Receivable financing	--1.24M	6.95%11.28M	-58.17%13.96M	-81.95%10.55M	123.68%33.39M	----	--58.43M	-40.35%14.93M	19.21%25.02M	--20.99M
Other current assets	--6.03M	361.78%4.16M	387.46%2.27M	-72.62%900K	--466.03K	----	--3.29M	----	-16.49%4.92M	--5.89M
Total current assets	--682.44M	18.12%644.1M	41.49%594.88M	18.54%545.28M	35.67%420.43M	----	--459.98M	33.50%309.89M	-3.08%232.14M	--239.51M
Non Current assets
Fixed assets	----	48.40%215.76M	53.19%218.31M	-1.33%145.39M	-5.16%142.51M	----	--147.35M	20.77%150.26M	14.22%124.42M	--108.93M
Constru in process	----	-6.65%184.63M	-20.71%144.6M	151.33%197.78M	445.89%182.36M	----	--78.69M	0.78%33.41M	-22.91%33.15M	--43M
Construction materials	----	7.29%6.25M	2.99%5.21M	-49.75%5.82M	203.63%5.06M	----	--11.59M	1.88%1.67M	87.62%1.64M	--871.55K
Intangible assets	--55.64M	-3.48%55.53M	-3.06%56.54M	0.27%57.53M	0.54%58.32M	----	--57.38M	184.20%58.01M	-19.47%20.41M	--25.34M
Deferred tax assets	--723.68K	-31.25%713.35K	85.87%669.31K	-11.89%1.04M	-49.74%360.1K	----	--1.18M	4.73%716.55K	75.86%684.18K	--389.05K
Usufruct assets	--883.86K	7.21%950.33K	-28.21%1.08M	-56.59%886.4K	-39.38%1.51M	----	--2.04M	93.94%2.49M	--1.28M	----
Other non current assets	--1.68M	-41.66%1.03M	56.23%1.72M	-94.57%1.77M	-57.34%1.1M	----	--32.66M	-59.59%2.58M	405.56%6.39M	--1.26M
Total non current assets	--470.27M	13.32%464.86M	9.43%428.13M	23.97%410.22M	57.04%391.22M	----	--330.89M	32.53%249.12M	4.55%187.97M	--179.79M
Total assets	--1.15B	16.06%1.11B	26.04%1.02B	20.82%955.49M	45.19%811.65M	--852.81M	--790.87M	33.07%559.02M	0.19%420.11M	--419.31M
Liabilities
Current liabilities
Short term loan	----	----	----	----	163.16%1M	----	--13.94M	-98.67%380K	-12.54%28.47M	--32.55M
Notes payable and accounts payable	--127.31M	-19.73%121.44M	6.26%144.5M	-2.54%151.29M	149.73%135.98M	----	--155.24M	-9.97%54.45M	3.10%60.49M	--58.66M
-Notes payable	--83.08M	-36.24%65.85M	9.67%97.73M	-9.60%103.27M	266.10%89.12M	----	--114.24M	-8.20%24.34M	-24.52%26.52M	--35.13M
-Accounts payable	--44.23M	15.77%55.6M	-0.22%46.77M	17.13%48.02M	55.65%46.87M	----	--41M	-11.36%30.11M	44.32%33.97M	--23.54M
Contract liabilities	--4.26M	-92.27%560.12K	53.37%4.39M	77.03%7.24M	-35.02%2.86M	----	--4.09M	87.12%4.4M	--2.35M	----
Advance receipts	----	----	----	----	----	----	----	----	----	--5.02M
Salaries payable	--11.15M	12.78%9.42M	-2.79%11.73M	1.39%8.35M	32.56%12.06M	----	--8.24M	53.50%9.1M	2.10%5.93M	--5.81M
Taxs payable	--6.74M	13.93%15.91M	53.30%6.54M	30.67%13.97M	-29.45%4.27M	----	--10.69M	616.67%6.05M	-29.42%843.95K	--1.2M
Other payable (including interest and dividends)	--351.19K	277.16%928.19K	-40.01%249.02K	-86.91%246.1K	-6.24%415.09K	----	--1.88M	30.75%442.7K	-99.33%338.59K	--50.81M
-Other payable	----	277.16%928.19K	-40.01%249.02K	-86.91%246.1K	-6.24%415.09K	----	--1.88M	30.75%442.7K	-99.33%338.59K	--50.81M
Non current liabilities due within one year	--266.23K	-49.99%263.15K	-73.64%256.98K	-51.48%526.23K	-11.06%974.98K	----	--1.08M	310.91%1.1M	--266.78K	----
Other current liabilities	--22.58M	-22.41%29.68M	78.85%46.49M	7.30%38.26M	-17.24%26M	----	--35.65M	33.70%31.41M	-18.30%23.49M	--28.76M
Total current liabilities	--172.65M	-18.95%178.21M	16.67%214.16M	-4.73%219.88M	71.02%183.56M	----	--230.81M	-12.15%107.33M	-33.17%122.18M	--182.81M
Current liabilities
Long term deferred income	----	----	----	----	----	----	----	----	----	--2.93M
Lease liabilities	--68.99K	-66.37%136.32K	-54.91%270.98K	-59.38%405.35K	-57.92%601.02K	----	--997.99K	42.04%1.43M	--1.01M	----
Total non current liabilities	--68.99K	-66.37%136.32K	-54.91%270.98K	-59.38%405.35K	-57.92%601.02K	----	--997.99K	42.04%1.43M	-65.73%1.01M	--2.93M
Total liabilities	--172.72M	-19.04%178.35M	16.44%214.43M	-4.97%220.29M	69.32%184.16M	--247.62M	--231.81M	-11.71%108.76M	-33.68%123.18M	--185.74M
Shareholders equity
Paid-in capital	--77.1M	0.00%77.1M	0.00%77.1M	0.00%77.1M	0.00%77.1M	----	--77.1M	5.04%77.1M	0.04%73.4M	--73.37M
Capital reserve funds	--239.82M	0.12%239.58M	0.21%239.32M	0.33%239.3M	0.24%238.83M	----	--238.52M	24.58%238.25M	117.01%191.24M	--88.12M
Surplus reserve funds	--49.1M	58.95%49.1M	58.95%49.1M	133.00%30.89M	133.00%30.89M	----	--13.26M	352.78%13.26M	-62.69%2.93M	--7.85M
Retained profit	--613.01M	46.88%564.43M	58.93%442.03M	68.52%384.29M	132.86%278.13M	----	--228.04M	351.08%119.44M	-56.02%26.48M	--60.2M
Specific reserves	--961.46K	-88.88%403.13K	-59.22%1.03M	68.65%3.62M	14.97%2.54M	----	--2.15M	-23.34%2.21M	-28.37%2.88M	--4.02M
Shareholders equity without minority interests	--979.99M	26.58%930.61M	28.86%808.58M	31.51%735.21M	39.36%627.49M	----	--559.07M	51.64%450.26M	27.13%296.92M	--233.56M
Total shareholder equity	--979.99M	26.58%930.61M	28.86%808.58M	31.51%735.21M	39.36%627.49M	--605.19M	--559.07M	51.64%450.26M	27.13%296.92M	--233.56M
Total liabilityies and equity	--1.15B	16.06%1.11B	26.04%1.02B	20.82%955.49M	45.19%811.65M	--852.81M	--790.87M	33.07%559.02M	0.19%420.11M	--419.31M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	Unqualified opinion	--	Unqualified opinion	--	--	Unqualified opinion	Unqualified opinion	Unqualified opinion
Auditor	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	Tianjian Certified Public Accountants (Special General Partnership)	Tianjian Certified Public Accountants (Special General Partnership)	Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

301617 Shandong Boyuan Pharmaceutical &Chemical

Shandong Boyuan Pharmaceutical &Chemical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target